Norges Bank Igm Biosciences, Inc. Transaction History

Norges Bank

$655 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$13.42 - $29.73 $462,493 - $1.02 Million	-34,463 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$27.59 - $66.39 $950,834 - $2.29 Million	34,463 New	34,463 $1.01 Million
Q3 2021 Nov 14, 2022	BUY	$65.76 - $90.65 $2.27 Million - $3.12 Million	34,463 New	34,463 $2.27 Million
Q3 2021 Nov 05, 2021	SELL	$65.76 - $90.65 $2.03 Million - $2.8 Million	-30,933 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$57.98 - $96.6 $1.79 Million - $2.99 Million	30,933 New	30,933 $2.57 Million
Q2 2021 Aug 10, 2021	SELL	$57.98 - $96.6 $1.79 Million - $2.99 Million	-30,933 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$71.56 - $121.23 $2.21 Million - $3.75 Million	30,933 New	30,933 $2.37 Million
Q1 2021 May 07, 2021	SELL	$71.56 - $121.23 $3.84 Million - $6.51 Million	-53,686 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$47.41 - $115.03 $2.55 Million - $6.18 Million	53,686 New	53,686 $4.74 Million
Q4 2020 Feb 10, 2021	SELL	$47.41 - $115.03 $2.55 Million - $6.18 Million	-53,686 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$43.0 - $84.01 $2.31 Million - $4.51 Million	53,686 New	53,686 $3.96 Million
Q3 2020 Nov 10, 2020	SELL	$43.0 - $84.01 $2.31 Million - $4.51 Million	-53,686 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$51.3 - $75.21 $2.75 Million - $4.04 Million	53,686 New	53,686 $3.92 Million
Q2 2020 Aug 07, 2020	SELL	$51.3 - $75.21 $1.08 Million - $1.58 Million	-21,069 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$31.51 - $73.75 $663,884 - $1.55 Million	21,069 New	21,069 $1.18 Million
Q1 2020 May 08, 2020	SELL	$31.51 - $73.75 $280,565 - $656,670	-8,904 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$17.25 - $49.51 $153,594 - $440,837	8,904 New	8,904 $340,000
Q4 2019 Feb 12, 2020	SELL	$17.25 - $49.51 $172,500 - $495,100	-10,000 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$17.75 - $24.3 $177,500 - $243,000	10,000 New	10,000 $178,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

21.4M

Call Options Held

39.5K

Put Options Held

16.5K

Baker Bros. Advisors LP New York, NY

4.09M
Shares

$70.6 Million
0.37% of portfolio
Price T Rowe Associates Inc Baltimore, MD

4.08M
Shares

$70.3 Million
0.0% of portfolio
Artal Group S.A. Luxembourg, N4

3.33M
Shares

$57.5 Million
1.45% of portfolio
Redmile Group, LLC San Francisco, CA

3.07M
Shares

$53 Million
1.38% of portfolio
Goldman Sachs Group Inc New York, NY

1.33M
Shares

$23 Million
0.0% of portfolio

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account